Investment
Features
FeesSafety
Academy
More
Pluang+

Baron launches BCEM ETF with active, forward-looking strategy for emerging markets growth.

Market News
02 Jul 2026
ETF Trends
View Source
Bullish
pluang ai news

Baron Capital introduced the Baron Emerging Markets Select ETF (BCEM), which employs an active, forward-looking investment approach to capture growth opportunities in emerging markets. Unlike traditional strategies relying on backward-looking indexes, BCEM focuses on identifying early structural inflection points through bottom-up fundamental research. Managed by Michael Kass, the ETF targets financially strong market leaders to manage risks amid the volatility and complexity of emerging markets. This active ETF offers investors flexibility and liquidity while aiming to capitalize on evolving global economic shifts.

More News

Lear Corporation beats Q2 2026 earnings and revenue estimates, raises full-year guidance.

Lear Corporation beats Q2 2026 earnings and revenue estimates, raises full-year guidance.

Lear Corporation reported strong Q2 2026 results with earnings per share of $4.28, surpassing analyst estimates of $3.89, and revenue of $6.21 billion, exceeding expectations of $6.14 billion. This marks consistent growth, driven by new business wins...

Company Fundamentals
Bullish
1 hour ago
Analyst lowers Grand Canyon Education price target to $200 despite strong Q2 earnings beating estimates.

Analyst lowers Grand Canyon Education price target to $200 despite strong Q2 earnings beating estimates.

Grand Canyon Education reported strong Q2 earnings of $1.81 per share, beating estimates of $1.69, with revenues of $264.05 million surpassing expectations. Despite this, an analyst from Barrington lowered the stock price target from $230 to $200, st...

Analyst Insights
Bullish
1 hour ago
Neurocrine Biosciences posts strong Q2 revenue growth and raises 2026 sales guidance.

Neurocrine Biosciences posts strong Q2 revenue growth and raises 2026 sales guidance.

Neurocrine Biosciences reported a 39% increase in Q2 2026 revenues to $959 million and non-GAAP earnings of $2.85 per share, beating estimates. Sales of its key drug INGREZZA rose 15% year-over-year, prompting the company to raise its 2026 sales fore...

Company Fundamentals
Bullish
1 hour ago
WisdomTree beats Q2 earnings and revenue estimates with strong financial health.

WisdomTree beats Q2 earnings and revenue estimates with strong financial health.

WisdomTree reported Q2 earnings per share of $0.31, surpassing analyst estimates of $0.26 and showing significant growth from $0.18 last year. The company also exceeded revenue expectations with $177.16 million, a 57.3% increase year-over-year. This ...

Company Fundamentals
Bullish
2 hours ago
Alpha Compute updates total shares outstanding to 72.8M, correcting market data underreporting

Alpha Compute updates total shares outstanding to 72.8M, correcting market data underreporting

Alpha Compute Corp., a leader in AI GPU-as-a-service and confidential computing, announced a correction to its total shares outstanding, now confirmed at 72,845,260 shares. This update addresses previous underreporting in market data feeds, ensuring ...

Market News
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App